Company Profile

Litmus Health Inc
Profile last edited on: 10/15/2019      CAGE: 7YDA2      UEI: PGAYLMDZMUN7

Business Identifier: Research-ready infrastructure/ data science platform for early-stage clinical trials
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1023 Springdale Road Building 5
Austin, TX 78721
   (727) 215-0447
Location: Single
Congr. District: 10
County: Travis

Public Profile

With facilities in Austn, TX, New York, NY amd Chicago. IL., Litmus Health is a data science platform for early-stage clinical trials. The firm's enterprise-ready end-to-end platform supports the entire trial process: from data collection at the point of experience to deep scientific analysis that influences decisions. Providing a robust infrastructure for high velocity, high volume data collection, storage, and analysis, taking into account the complexities of synchronizing multiple devices, sensors, and data streams, principals of the firm help researchers make better "go" and "no-go" decisions from patientsÂ’ environment, lifestyle, diet, and activity. Validating data collected at the point of experience from wearables, smart devices, and home sensors, the result is a multi-dimensional outlook that guides management and informs trial endpoints.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Daphne Kis -- Co-Founder, Business and Operations

  James Crooks -- VP Engineering

  Josh Jones-Dilworth -- Co-Founder, Sales and Marketing

  Dominiek Ter Heide -- Chief Technology Officer

  Sam Volchenboum -- Chief Medical Officer

Company News

There are no news available.